Related Experiment Video
Updated: Feb 19, 2026

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
Characteristics of severe hypoglycemia in the patient with insulin-dependent diabetes
Abstract:
To avoid, delay, or ameliorate the microvascular complications of diabetes, intensive insulin therapy with the goal of normoglycemia is required. In most patients with insulin-dependent diabetes mellitus (IDDM), this cannot be achieved because of severe hypoglycemia, which is one of the major causes of morbidity in diabetic patients. To assess the frequency and characteristics of severe hypoglycemia in a single diabetologist's practice, we surveyed 211 consecutive patients with IDDM for a history of severe hypoglycemia (SH), defined as events requiring the assistance of another person. Of these 211 patients, 135 (64%) had at some time had SH. Those with SH had a longer duration of IDDM, currently took more insulin injections, had a higher prevalence of neuropathy and nephropathy, and were less likely to be using human insulin. No difference was found in age, average glycosylated hemoglobin level, frequency of home glucose monitoring, or presence of retinopathy. Half of the patients with SH had confusion and were treated with glucose orally. The remainder were in coma and received i.v. glucose or IM glucagon. Perceived causes of SH were lack of food, excessive insulin, and unusual exercise. We conclude that the frequency of SH is underestimated in clinical practice. Risk factors for SH are longer duration of IDDM, presence of neuropathy and nephropathy, and use of animal insulin. Better education in avoidance and treatment of SH would reduce the morbidity of SH.
Insights
Severe hypoglycemia is common in insulin-dependent diabetes mellitus (IDDM), affecting 64% of patients. Risk factors include longer diabetes duration and animal insulin use, highlighting the need for better patient education.
Area of Science:
- Endocrinology
- Diabetology
- Metabolic Diseases
Background:
- Intensive insulin therapy aims to prevent diabetes complications.
- Severe hypoglycemia (SH) is a major cause of morbidity in diabetic patients.
- Achieving normoglycemia is often hindered by SH in insulin-dependent diabetes mellitus (IDDM).
Purpose of the Study:
- To determine the frequency and characteristics of SH in a diabetologist's practice.
- To identify risk factors associated with SH in IDDM patients.
Main Methods:
- Survey of 211 consecutive IDDM patients for history of SH.
- SH defined as events requiring assistance from another person.
- Analysis of patient characteristics and SH history.
Main Results:
- 64% of patients reported a history of SH.
- SH associated with longer IDDM duration, higher insulin doses, and presence of neuropathy/nephropathy.
- Patients with SH were less likely to use human insulin.
Conclusions:
- The frequency of SH is likely underestimated in clinical practice.
- Longer diabetes duration, neuropathy, nephropathy, and animal insulin use are risk factors for SH.
- Improved patient education on SH avoidance and management is crucial.
Related Concept Videos
Hypoglycemia and Glucagon
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

